rawfin.tv
New Biotech Firm Co-Founded by Georg Schett Plans Antibody Therapies
MarketsstocksAI Generated

New Biotech Firm Co-Founded by Georg Schett Plans Antibody Therapies

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

A new biotech company, co-founded by renowned autoimmune researcher Georg Schett, has unveiled its plans to develop antibody therapies. Schett is recognized for his pioneering work in autoimmune disease treatment.

BiotechAutoimmuneDrug DevelopmentAntibody TherapiesPharmaceuticals

Related Articles

S&P 500 Faces 30% Drop in $20T AI Bust, TS Lombard Warns

S&P 500 Faces 30% Drop in $20T AI Bust, TS Lombard Warns

stocks
Nasdaq Smashed and Dow Drops as Oil Jumps on Geopolitical Tensions

Nasdaq Smashed and Dow Drops as Oil Jumps on Geopolitical Tensions

stocks
Asian Equities Plunge And Bitcoin Retreats As Chinese Markets Enter Bear Territory

Asian Equities Plunge And Bitcoin Retreats As Chinese Markets Enter Bear Territory

stocks
Barclays Workforce Trimmed 5% as Bank Increases Focus on AI

Barclays Workforce Trimmed 5% as Bank Increases Focus on AI

stocks